SCHEMBL1836306

SCHEMBL1836306

Nc1ncccc1OC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.53
LTA4H P09960 1/20 0.51
MAPK14 Q16539 1/20 0.51
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
PRKCI P41743 2/20 0.44
HTT P42858 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 3/20 0.41
SHMT2 P34897 1/20 0.41
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
MKNK2 Q9HBH9 1/20 0.41
NOS3 P29474 1/20 0.41
NOS1 P29475 1/20 0.41
NOS2 P35228 1/20 0.41
MAPT P10636 2/20 0.41
HSP90AA1 P07900 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1767046 0.85 NAPRT (0.48) NAPRTLTA4HMAPK14NPC1RAB9A
SCHEMBL27724284 0.83 KDM4E (0.50) NAPRTLTA4HMAPK14NPC1RAB9A
SCHEMBL10569219 0.82 LMNA (0.63) NAPRTLTA4HMAPK14NPC1RAB9A
SCHEMBL5702580 0.80 KDM4E (0.50) NAPRTHTTSMN1; SMN2LMNAMETAP2
SCHEMBL22583116 0.79 ALDH1A1 (0.49) NAPRTLTA4HMAPK14NPC1RAB9A
SCHEMBL377461 0.78 LMNA (0.42) NAPRTHTTSMN1; SMN2LMNAMETAP2
SCHEMBL2919947 0.77 NAPRT (0.53) NAPRTHTTLMNAMETAP2METAP1
SCHEMBL5178813 0.77 SMN1; SMN2 (0.53) NPC1RAB9AHTTSMN1; SMN2LMNA
SCHEMBL10873387 0.77 LMNA (0.41) NAPRTNPC1RAB9AHTTSMN1; SMN2
SCHEMBL10723234 0.77 LTA4H (0.47) NAPRTLTA4HMAPK14NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1970470-B1 Chrome(VI)-free black passivates for surfaces containing zinc ATOTECH DEUTSCHLAND GMBH (DE) 2011-05-11 EP claimed
EP-1970470-A1 Chrome(VI)-free black passivates for surfaces containing zinc ATOTECH DEUTSCHLAND GMBH (DE) 2008-09-17 EP claimed
WO-2008107039-A1 CHROMIUM(VI)-FREE BLACK PASSIVATION OF SURFACES CONTAINING ZINC ATOTECH DEUTSCHLAND GMBH (DE) 2008-09-12 WO claimed
EP-2358922-B1 CONVERSION LAYERS FOR SURFACES CONTAINING ZINC ATOTECH DEUTSCHLAND GMBH (DE) 2016-01-27 EP disclosed
EP-2358922-A1 CONVERSION LAYERS FOR SURFACES CONTAINING ZINC ATOTECH Deutschland GmbH (DE) 2011-08-24 EP disclosed
EP-1970470-B1 Chrome(VI)-free black passivates for surfaces containing zinc ATOTECH DEUTSCHLAND GMBH (DE) 2011-05-11 EP disclosed
WO-2010060883-A1 CONVERSION LAYERS FOR SURFACES CONTAINING ZINC ATOTECH DEUTSCHLAND GMBH (DE) 2010-06-03 WO disclosed
EP-1970470-A1 Chrome(VI)-free black passivates for surfaces containing zinc ATOTECH DEUTSCHLAND GMBH (DE) 2008-09-17 EP disclosed
WO-2008107039-A1 CHROMIUM(VI)-FREE BLACK PASSIVATION OF SURFACES CONTAINING ZINC ATOTECH DEUTSCHLAND GMBH (DE) 2008-09-12 WO disclosed
EP-1928868-A1 IMINOOXAZOLIDINE DERIVATIVES AND USE THEREOF Bayer HealthCare AG (DE) 2008-06-11 EP disclosed
WO-2007028520-A1 IMINOOXAZOLIDINE DERIVATIVES AND USE THEREOF BAYER HEALTHCARE AG (DE) 2007-03-15 WO disclosed
EP-1648890-A2 ARYL-CONDENSED 3-ARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2006-04-26 EP disclosed
WO-2005010000-A2 ARYL-CONDENSED 3-ARYLPYRIDINE COMPOUNDS AND USE THEREOF FOR CONTROLLING PATHOGENIC FUNGI BASF AKTIENGESELLSCHAFT (DE) 2005-02-03 WO disclosed
WO-1997007131-A1 ACYLATED OLIGOPEPTIDES CONTAINING PHOSPHOTYROSINE AS INHIBITORS OF PROTEIN TYROSINE KINASES NOVARTIS AG (CH) 1997-02-27 WO disclosed
EP-0668278-A1 Adhesion receptor antagonists MERCK PATENT GmbH (DE) 1995-08-23 EP disclosed